General Information of Drug (ID: DMJ2PG1)

Drug Name
VTHRLAGLLSRSGGVVKNNFVPTNVGSKAF-NH2 Drug Info
Synonyms
CHEMBL525571; alpha-Cgrp (8-37); Val(8)-phe(37)-cgrp; CGRP8-37; CGRP-(8-37); Calcitonin gene-related peptide (8-37); h alpha-CGRP8-37; 8-Val-37-phe-calcitonin gene-related peptide; Calcitonin gene-related peptide, val(8)-phe(37)-; Calcitonin gene-related peptide, valyl(8)-phenylalanine(37)-; BDBM50000743; NCGC00167246-01; CALCITONIN GENE RELATED PEPTIDE (8-37); [Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asn-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH2] hC; alpha-Calcitonin gene-r
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
16134896
CAS Number
CAS 119911-68-1
TTD Drug ID
DMJ2PG1

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cizolirtine DMOFTRE Neuropathic pain 8E43.0 Phase 2 [2]
FV-Aib-TDVGPFAF DMEI890 Discovery agent N.A. Investigative [1]
Ac-WVTH[hArg]LAGLLS[hArg]SGGVVRKNFVPTDVGPFAF-NH2 DM19NMF Discovery agent N.A. Investigative [1]
Ac-WVEHRLKGELSRKGGVV[hArg]KNFVPTDVGPFAF-NH2 DM9W21L Discovery agent N.A. Investigative [1]
Ac-WVTHQLAGLLSQSGGVVRKNFVPTDVGPFAF-NH2 DM3BUP6 Discovery agent N.A. Investigative [1]
Ac-VTHRLAGLLSRSGGVVKNNFVPTDVGPFAF-NH2 DMO0W9V Discovery agent N.A. Investigative [1]
Ac-WVTHRLAGLLSRSGGVVRKNFVPTDVGPFAF-NH2 DMSMVK4 Discovery agent N.A. Investigative [1]
Ac-WVTH[Cit]LAGLLSRSGGVVRKNFVPTDVGPFAF-NH2 DMR1N53 Discovery agent N.A. Investigative [1]
Ac-WVTHRLAGLLS[Cit]SGGVVRKNFVPTDVGPFAF-NH2 DMKO982 Discovery agent N.A. Investigative [1]
Ac-WVTH[Cit]LAGLLS[Cit]SGGVVRKNFVPTDVGPFAF-NH2 DMJU4AM Discovery agent N.A. Investigative [1]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Calcitonin gene-related peptide 1 (CALCA) TTVSFJW CALCA_HUMAN Inhibitor [1]

References

1 Identification of potent, selective, and metabolically stable peptide antagonists to the calcitonin gene-related peptide (CGRP) receptor. J Med Chem. 2008 Dec 25;51(24):7889-97.
2 Emerging drugs in neuropathic pain. Expert Opin Emerg Drugs. 2007 Mar;12(1):113-26.